Center for Responsive Politics

See the following -

An Epic conflict of interest

Pejman Yousefzadeh | The Daily Caller | December 27, 2011

Meet Judy Faulkner. She is the founder and CEO of Epic Systems Corporation in Wisconsin. She is also a member of the GAO Health Information Technology Policy Committee and an advisory board member of the Journal of Healthcare Information Management. She is also politically active...The $787 billion stimulus bill signed into law by President Obama in February 2009 included $19 billion for healthcare information technology (HIT), and created the Health IT Policy Committee, whose job it was to advise the federal government on spending the $19 billion allocation. The committee was to have one member responsible for representing information technology vendors. Judy Faulkner was designated as that member.

Read More »

Mother Jones piece hits Epic hard: 5 criticisms of the EHR vendor

Akanksha Jayanthi | Becker's Health IT and CIO Review | October 26, 2015

For a company that is notorious for its lack of media interaction, Epic Systems often finds itself in headlines, for better or for worse. The latest Epic media storm was delivered by a Mother Jones piece in which the author criticized the vendor and the health IT marketplace as failing in its mission to help patients and save money through digitization. Author Patrick Caldwell wrote the healthcare industry has largely underachieved in its goal to digitize medical records and cut waste and costs associated with paper records.

Read More »

Winners And Losers With The 21st Century Cures Bill

Sydney Lupkin and Steven Findlay | NPR | December 2, 2016

A sprawling health bill that passed the Senate Thursday by a 94 to 5 vote and is expected to gain President Obama's signature is a grab bag for industries, academic institutions and patient groups that spent oodles of time and money lobbying to advance their interests. Senate Majority Leader Mitch McConnell calls it "the most important legislation that Congress will pass this year." Who wins and who loses? Here's the rundown of what's at stake in the 21st Century Cures Act...

Read More »